BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liberelle M, Toulotte F, Renault N, Gelin M, Allemand F, Melnyk P, Guichou JF, Cotelle P. Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs. J Med Chem 2022. [PMID: 35389210 DOI: 10.1021/acs.jmedchem.2c00075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pobbati AV, Kumar R, Rubin BP, Hong W. Therapeutic targeting of TEAD transcription factors in cancer. Trends Biochem Sci 2023:S0968-0004(22)00333-4. [PMID: 36709077 DOI: 10.1016/j.tibs.2022.12.005] [Reference Citation Analysis]
2 Lou J, Lu Y, Cheng J, Zhou F, Yan Z, Zhang D, Meng X, Zhao Y. A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities. European Journal of Medicinal Chemistry 2022;243:114684. [DOI: 10.1016/j.ejmech.2022.114684] [Reference Citation Analysis]
3 Gridnev A, Maity S, Misra JR. Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1021823] [Reference Citation Analysis]
4 Zagiel B, Melnyk P, Cotelle P. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present). Expert Opin Ther Pat 2022;:1-14. [PMID: 35768160 DOI: 10.1080/13543776.2022.2096436] [Reference Citation Analysis]